An anonymous representative of Apollo reports

APOLLO CAPITAL RELEASES INVESTOR PRESENTATION HIGHLIGHTING PLAN TO MAKE MEDIPHARM LABS THE WORLD'S LEADING INTERNATIONAL MEDICAL CANNABIS COMPANY

Apollo Technology Capital Corp., which together with its affiliates and associates collectively is one of the largest shareholders of Medipharm Labs Corp., owning approximately 3 per cent of the company's common stock, has issued a presentation to set forth its ambitious plan to increase your investment and help turn Medipharm around.

• Outlines commitment to immediately and aggressively execute on action plan to 10 times plus share price and create value for all shareholders;
• Details specific and measurable initiatives to save Medipharm Labs from insolvency at the hands of greedy, reckless and maligned leaders;
• Sets forth plan to stop exorbitant executive compensation pay for failure and end three years of value-destructive actions.

The time to act is now. Vote the gold card today.

Shareholders are urged to protect their investment by voting the gold proxy card for Apollo Capital's six highly qualified director nominees and disregard Medipharm Labs' green proxy card.

Save Medipharm and deliver the value that shareholders deserve.

We seek Safe Harbor.